218 related articles for article (PubMed ID: 30820785)
1. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
Onuma AE; Beal EW; Nabhan F; Hughes T; Farrar WB; Phay J; Ringel MD; Kloos RT; Shirley LA
Ann Surg Oncol; 2019 Jun; 26(6):1737-1743. PubMed ID: 30820785
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.
Al-Saif O; Farrar WB; Bloomston M; Porter K; Ringel MD; Kloos RT
J Clin Endocrinol Metab; 2010 May; 95(5):2187-94. PubMed ID: 20332244
[TBL] [Abstract][Full Text] [Related]
3. The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.
Sun W; Di L; Chen L; Li D; Wu Y; Xiang J; Zhou S; Sun T
BMC Surg; 2022 Nov; 22(1):374. PubMed ID: 36324095
[TBL] [Abstract][Full Text] [Related]
4. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence.
Palmer BA; Zarroug AE; Poley RN; Kollars JP; Moir CR
J Pediatr Surg; 2005 Aug; 40(8):1284-8. PubMed ID: 16080933
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
8. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
Yim JH; Kim WB; Kim EY; Kim WG; Kim TY; Ryu JS; Gong G; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2011 Jul; 96(7):2049-56. PubMed ID: 21508143
[TBL] [Abstract][Full Text] [Related]
9. Radio-guided excision of metastatic lymph nodes in thyroid carcinoma: a safe technique for previously operated neck compartments.
Erbil Y; Sari S; Ağcaoğlu O; Ersöz F; Bayraktar A; Salmaslioğlu A; Gozkun O; Adalet I; Ozarmağan S
World J Surg; 2010 Nov; 34(11):2581-8. PubMed ID: 20632005
[TBL] [Abstract][Full Text] [Related]
10. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
Hall CM; LaSeur DC; Snyder SK; Lairmore TC
Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
12. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
14. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
15. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
16. A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study.
Lee JH; Chung YS; Lee YD
Head Neck; 2017 Apr; 39(4):767-771. PubMed ID: 28139038
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.
Rivera-Robledo CG; Velázquez-Fernández D; Pantoja JP; Sierra M; Pérez-Enriquez B; Rivera-Moscoso R; Chapa M; Herrera MF
World J Surg; 2019 Nov; 43(11):2842-2849. PubMed ID: 31372725
[TBL] [Abstract][Full Text] [Related]
18. Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.
Alzahrani AS; Raef H; Sultan A; Al Sobhi S; Ingemansson S; Ahmed M; Al Mahfouz A
J Endocrinol Invest; 2002 Jun; 25(6):526-31. PubMed ID: 12109624
[TBL] [Abstract][Full Text] [Related]
19. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
[TBL] [Abstract][Full Text] [Related]
20. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
